The use of specific antagonists to integrins as well as their ligands, has been able to prevent inflammation and angiogenesis in the CIA mouse model; furthermore high levels of soluble and endothelium-bound ICAM-1 have been identified in RA patients, as well as being linked to disease activity in CIA model mice (138–140). The gene discussed is ICAM1; the disease is rheumatoid arthritis.